Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
In the latest session, Theravance Biopharma Inc (NASDAQ: TBPH) closed at $8.84 up 4.74% from its previous closing price of $8.44. In other words, the price has increased by $4.74 from its previous closing price. On the day, 2.06 million shares were traded. TBPH stock price reached its highest trading level at $8.98 during the session, while it also had its lowest trading level at $8.4.
Ratios:
For a deeper understanding of Theravance Biopharma Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.39 and its Current Ratio is at 5.39. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.21.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on April 12, 2024, initiated with a Buy rating and assigned the stock a target price of $21.
On May 23, 2022, SVB Leerink started tracking the stock assigning a Outperform rating and target price of $12.SVB Leerink initiated its Outperform rating on May 23, 2022, with a $12 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 22 ’24 when Farnum Rhonda sold 1,254 shares for $8.71 per share. The transaction valued at 10,922 led to the insider holds 311,733 shares of the business.
Farnum Rhonda sold 1,378 shares of TBPH for $14,180 on Nov 21 ’23. The SVP, COMM & MEDICAL AFFAIRS now owns 331,206 shares after completing the transaction at $10.29 per share. On Nov 14 ’23, another insider, GRAHAM RICHARD A, who serves as the SVP, RESEARCH & DEVELOPMENT of the company, sold 2,482 shares for $10.22 each. As a result, the insider received 25,366 and left with 346,839 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TBPH now has a Market Capitalization of 429270400 and an Enterprise Value of 372509024. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.41 while its Price-to-Book (P/B) ratio in mrq is 2.00. Its current Enterprise Value per Revenue stands at 6.487 whereas that against EBITDA is -7.004.
Stock Price History:
Over the past 52 weeks, TBPH has reached a high of $11.98, while it has fallen to a 52-week low of $8.21. The 50-Day Moving Average of the stock is -2.55%, while the 200-Day Moving Average is calculated to be -7.94%.
Shares Statistics:
For the past three months, TBPH has traded an average of 373.05K shares per day and 510710 over the past ten days. A total of 48.09M shares are outstanding, with a floating share count of 43.68M. Insiders hold about 9.32% of the company’s shares, while institutions hold 101.64% stake in the company. Shares short for TBPH as of 1713139200 were 6429741 with a Short Ratio of 17.24, compared to 1710460800 on 8404365. Therefore, it implies a Short% of Shares Outstanding of 6429741 and a Short% of Float of 26.029999999999998.
